Law360, New York (October 01, 2009) -- A federal judge has ruled that a securities class action can continue against Par Pharmaceutical Cos. Inc.’s former chief executive officer and a former vice president, but has cleared one former head of the company from the case.
Judge Peter G. Sheridan of the U.S. District Court for the District of New Jersey on Wednesday determined that company shareholders could pursue claims that Scott Tarriff, Par’s former CEO...
